Background And Aims: Secreted protein acidic and rich in cysteine (SPARC) is involved in the pathological processes of many metabolic diseases. However, studies on the relevance of SPARC to hypertension and its involvement in endothelial function are scarce. In this study, we aim to explore the relevance of SPARC to hypertension and investigate its role in endothelium-dependent relaxation (EDR).
Methods: 110 patients who met the criteria were recruited as participants. Serum SPARC concentrations were determined by Luminex assay. The correlation between SPARC levels and hypertension was analyzed. After treatment with SPARC ex vivo or in vivo, endothelial-dependent relaxation (EDR) was measured by wire myography. Western blotting was performed to detect the expression of proteins relevant to endothelial function.
Results: Our results showed that serum SPARC levels were significantly higher in the hypertensive group and were positively associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP). Functional results demonstrated that SPARC dramatically impaired EDR and induced the excess production of reactive oxygen species (ROS) in endothelial cells. Further experimental results confirmed that SPARC reduced angiotensin-converting enzyme 2 (ACE2) expression and ACE2 overexpression or activation completely abolished the impairing effect of SPARC on endothelial function.
Conclusions: The present study reveals the correlation between elevated SPARC and hypertension and confirms its adverse effect on endothelial function, helping establish a comprehensive understanding of hypertension-related endothelial dysfunction in a new scope.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2023.117390 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Elevated Serum Extracellular Vesicle-Packaged SPARC in Hypertension: A Cross-Sectional Study in a Middle-Aged and Elderly Population.
J Clin Hypertens (Greenwich)
December 2024
Beijing An Zhen Hospital, Capital Medical University, The Key Laboratory of Remodeling Cardiovascular Diseases, Ministry of Education; Collaborative Innovation Center for Cardiovascular Disorders, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Article Synopsis
- * This research involved 125 Chinese participants, comparing serum EV-derived SPARC levels between 76 hypertension patients and 49 normotensive individuals.
- * Results showed that those with hypertension had significantly higher serum EV-derived SPARC levels (20.60 ng/mL) compared to normotensive subjects (14.25 ng/mL), suggesting that these elevated SPARC levels are independently associated with hypertension.
Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer.
Br J Cancer
November 2024
Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Article Synopsis
- * Researchers tested the anti-hypertensive drug losartan in ovarian cancer models, discovering that it improves the tumor microenvironment and enhances drug delivery and immune cell activity while also making cancer cells more sensitive to chemotherapy.
- * Given its safety and low cost, losartan could be a promising addition to treatments for ovarian cancer, potentially improving outcomes for patients.
Exploring the roles of SPARC as a proinflammatory factor and its potential as a novel therapeutic target against cardiovascular disease.
Am J Physiol Heart Circ Physiol
November 2024
Department of Pharmacology, Educational Foundation of Osaka Medical and Pharmacological University, Takatsuki, Japan.
Article Synopsis
- Cardiovascular disease (CVD) is a major global health issue, with its prevalence rising despite significant research efforts, highlighting the role of chronic inflammation in this condition.
- The protein SPARC, which binds to collagen and is involved in tissue remodeling, has been linked to increased inflammation and is associated with conditions like hypertension and obesity.
- This review focuses on SPARC's negative impact on CVD and other diseases, suggesting that measuring and inhibiting SPARC could be key in developing new prevention and treatment strategies.
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes.
Mol Neurobiol
July 2024
Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Patients with hemorrhagic stroke have high rates of morbidity and mortality, and drugs for prevention are very limited. Mendelian randomization (MR) analysis can increase the success rate of drug development by providing genetic evidence. Previous MR analyses only analyzed the role of individual drug target genes in hemorrhagic stroke; therefore, we used MR analysis to systematically explore the druggable genes for hemorrhagic stroke.
View Article and Find Full Text PDFExpression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing.
Neoplasia
July 2024
Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Robert-Koch-Straße 40, 37075 Goettingen, Germany; Clinical Research Unit KFO5002, University Medical Center Goettingen, Goettingen, Germany. Electronic address:
Background: Pancreatic ductal adenocarcinoma (PDAC) poorly responds to antineoplastic agents. Discrepancies between preclinical success and clinical failure of compounds has been a continuous challenge and major obstacle in PDAC research.
Aim: To investigate the association of the tumor microenvironment (TME) composition and gemcitabine metabolizing enzyme (GME) expression in vitro and several in vivo models.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!